Does Quartz Health Solutions Cover Metformin? A Woman's Complete Guide

What Is Quartz Health Solutions and How Does Its Formulary Work?

Quartz Health Solutions is a Wisconsin-based regional health insurer offering individual, employer-sponsored, and Medicare Advantage plans primarily across Wisconsin, Minnesota, Iowa, and Illinois. Like most insurers, Quartz uses a tiered formulary, a ranked drug list that determines your out-of-pocket cost. Generic drugs with strong safety records tend to land on Tier 1, the lowest-cost category, while brand-name or specialty drugs sit on higher tiers with steeper copays or coinsurance.

Understanding Tier Placement for Metformin

Metformin hydrochloride has been off-patent for decades. Because it is one of the most prescribed generic drugs in the United States, appearing on the medications list of roughly 37 million Americans with type 2 diabetes, virtually every commercial formulary places it at Tier 1. Quartz is no exception for the approved type 2 diabetes indication.

Your specific copay depends on three things: which Quartz plan you hold (HMO, PPO, or high-deductible health plan), whether you are in a deductible phase, and whether you use a preferred in-network pharmacy or mail order. Quartz's mail-order pharmacy typically offers a 90-day supply at a lower unit cost than a 30-day retail fill, so if you take metformin daily, ask your prescriber to write a 90-day supply.

When Prior Authorization May Apply

Prior authorization (PA) is not unusual for off-label metformin use. If your prescriber writes metformin for PCOS, prediabetes, or metabolic syndrome without a type 2 diabetes diagnosis code on the claim, Quartz's system may trigger a PA request. This does not mean automatic denial. It means your clinician needs to submit clinical notes and relevant lab values (fasting glucose, hemoglobin A1c, HOMA-IR if available) to justify medical necessity.

A PA approval typically lasts 12 months and must be renewed. If you are denied, you have the right to appeal, and your clinician can submit peer-reviewed evidence supporting metformin's use in your specific condition.

Metformin and Women's Health: Why So Many Women Are Prescribed It

Metformin is not just a diabetes drug. For women, it touches a remarkable number of conditions tied directly to hormonal status and metabolic function across every life stage.

Reproductive-Age Women and PCOS

Polycystic ovary syndrome affects roughly 8 to 13 percent of reproductive-age women, making it one of the most common endocrine disorders in this age group. Insulin resistance sits at the core of PCOS pathophysiology even when blood glucose looks normal, and metformin directly lowers hepatic glucose output and improves insulin sensitivity.

The American College of Obstetricians and Gynecologists notes in its PCOS practice bulletin that metformin may improve menstrual regularity, lower androgen levels, and reduce the metabolic risks associated with PCOS, though it is not FDA-approved specifically for this indication. ACOG Practice Bulletin Number 194 states that metformin is a reasonable adjunct for ovulation induction and metabolic management in women with PCOS who do not respond to or cannot tolerate first-line lifestyle interventions alone.

Because PCOS is an off-label use, your Quartz plan may require a PA. Your clinician's documentation should include your PCOS diagnosis code (E28.2), your fasting insulin or HOMA-IR, and any menstrual irregularity data.

Prediabetes and Insulin Resistance

The Diabetes Prevention Program trial, which enrolled over 3,000 participants with prediabetes, found that metformin 850 mg twice daily reduced the incidence of type 2 diabetes by 31 percent over roughly three years compared with placebo. Lifestyle modification reduced it by 58 percent, but for women who cannot meet lifestyle targets, or who have multiple risk factors including a history of gestational diabetes, metformin is a well-supported option.

The American Diabetes Association's 2024 Standards of Care recommend considering metformin for prediabetes, especially in women with a body mass index of 35 or above, women under 60 years old, or women with a history of gestational diabetes. ADA Standards of Medical Care in Diabetes 2024 note that gestational diabetes history is a particularly strong indication. This is clinically meaningful: women with gestational diabetes have a 50 percent lifetime risk of developing type 2 diabetes, a risk that metformin may blunt.

Perimenopause and Postmenopause: The Metabolic Shift

The hormonal changes of perimenopause, roughly the decade before the final menstrual period, change how your body handles glucose. Estrogen has direct effects on insulin sensitivity and pancreatic beta-cell function. As estrogen declines, many women experience worsening insulin resistance even without weight gain. Some clinicians prescribe metformin off-label during this window to stabilize metabolic function, particularly in women who are not yet candidates for menopausal hormone therapy or who have contraindications to it.

Evidence directly studying metformin in perimenopausal and postmenopausal women without diabetes is limited, which is worth being honest about. Most of what we know is extrapolated from trials in younger women or from mixed-sex diabetes trials. If your clinician recommends metformin in perimenopause for metabolic reasons, that is a reasonable clinical judgment, but Quartz is less likely to approve a PA for this indication without supporting metabolic lab data.

Sex-Specific Pharmacology: How Metformin Behaves Differently in Women

Women absorb and distribute metformin somewhat differently than men, a distinction that rarely appears in patient-facing resources.

Pharmacokinetics in Women

Women tend to have a lower volume of distribution for metformin due to differences in lean body mass and renal tubular secretion capacity. Studies of metformin pharmacokinetics show that plasma concentrations may run modestly higher in women at the same weight-adjusted dose, which could contribute to the higher rate of gastrointestinal side effects reported by women in observational data. A pharmacokinetic analysis published in Clinical Pharmacokinetics found sex was a significant covariate for metformin clearance.

Practically: if you are starting metformin and experiencing significant nausea or diarrhea, ask your clinician about starting at 500 mg once daily with the evening meal and titrating slowly over four to six weeks rather than jumping to the standard 500 mg twice-daily initiation. The extended-release formulation (metformin ER) also tends to produce fewer GI complaints and may be worth requesting if Quartz covers it at a similar tier as immediate-release.

The Menstrual Cycle and Metformin Timing

Insulin sensitivity naturally fluctuates across the menstrual cycle: it tends to be higher in the follicular phase (days 1 to 14) and lower in the luteal phase (days 15 to 28) due to progesterone's insulin-antagonizing effect. Metformin blunts this swing somewhat, which is one reason it can improve the hormonal irregularity of PCOS. You don't need to time your doses to cycle phase, but knowing this explains why some women notice slightly better glucose control in the first half of their cycle.

Pregnancy, Lactation, and Contraception: What Every Woman Must Know

This section applies to any woman of reproductive age who is prescribed or considering metformin.

Pregnancy Safety

Metformin crosses the placenta. This is documented, not theoretical. Studies of women with gestational diabetes and PCOS have used metformin in pregnancy with generally reassuring short-term neonatal outcomes, but long-term follow-up data on offspring metabolic health is still accumulating and some signals warrant caution.

The MiG Trial (Metformin in Gestational Diabetes), published in the New England Journal of Medicine, found that metformin was not inferior to insulin for glycemic control in gestational diabetes and was associated with less maternal weight gain and lower rates of neonatal hypoglycemia. However, neonates in the metformin group had higher rates of preterm birth, a finding that has not been fully resolved across subsequent trials.

ACOG currently considers metformin an acceptable alternative to insulin in gestational diabetes management for motivated patients who prefer oral therapy. If you become pregnant while taking metformin for PCOS or prediabetes, do not stop the medication abruptly without talking to your OB or midwife first. Glycemic control in early pregnancy matters for fetal neural tube development.

Metformin is not classified as a teratogen under the older FDA category system, and it does not require contraception the way a drug like isotretinoin does. Still, if you are trying to conceive, your care plan for PCOS or prediabetes should be discussed with a reproductive endocrinologist or OB before you stop contraception.

Lactation

Metformin is present in breast milk at low concentrations. A study published in Diabetes Care found infant exposure via breast milk was estimated at 0.28 percent of the weight-adjusted maternal dose, which is well below the 10 percent threshold generally used to define clinically significant infant exposure. The infant plasma concentrations measured in that study were undetectable or very low. Most professional bodies, including the Academy of Breastfeeding Medicine, consider metformin compatible with breastfeeding, though you should confirm this with your prescriber given your specific clinical picture.

Contraception Reminder

Metformin itself does not require contraception, but women with PCOS who start metformin should know that ovulatory function can restore as insulin resistance improves. If you were not ovulating regularly and relied on that as informal pregnancy prevention, that assumption becomes unreliable once metformin is working. Use reliable contraception if pregnancy is not your goal.

Who Metformin Is Right For, and Who Should Think Twice

Women Who Are Good Candidates

• Reproductive-age women with PCOS and insulin resistance, particularly those with irregular cycles, elevated fasting insulin, or a family history of type 2 diabetes
• Women with prediabetes (fasting glucose 100 to 125 mg/dL or A1c 5.7 to 6.4 percent) who have not been able to meet lifestyle targets after six months of structured effort
• Women with gestational diabetes history who want to reduce their lifetime diabetes risk
• Perimenopausal women with worsening insulin resistance and metabolic syndrome features, in consultation with a clinician who can monitor renal function

Women Who Should Use Caution or Avoid Metformin

Metformin is contraindicated in women with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73 m², because it accumulates and raises the risk of lactic acidosis. Use requires caution (and dose adjustment) when eGFR is between 30 and 45. Women with active liver disease, a recent history of alcohol use disorder, or who are scheduled for contrast-enhanced imaging (hold metformin before and 48 hours after IV contrast) should discuss timing with their prescriber.

Women with B12 deficiency should know that long-term metformin use is associated with reduced B12 absorption in the terminal ileum. A randomized trial published in the BMJ found that metformin users had a 19 percent lower serum B12 concentration than placebo after four years. If you have been on metformin for more than a year, ask your clinician to check your B12 level annually, especially if you follow a plant-based diet or have a history of pernicious anemia.

How to Check Your Actual Quartz Coverage for Metformin

Reading this article gives you a framework, but your actual cost depends on your exact plan. Here is a practical checklist.

Step-by-Step Coverage Verification

1. Log into your Quartz member portal at quartzbenefits.com and manage to "Drug Coverage" or "Formulary Search." Enter "metformin hydrochloride" and your prescribed dose (500 mg, 850 mg, or 1000 mg, immediate-release or extended-release).

2. Note the tier number. Tier 1 means the lowest copay. If metformin ER lands on Tier 2 or 3, ask your prescriber whether immediate-release at Tier 1 is clinically appropriate for you.

3. Check whether your plan has a deductible that applies to prescriptions. Some high-deductible health plans require you to pay full generic price until the deductible is met, even for Tier 1 drugs.

4. Call the member services number on the back of your insurance card if the portal result is unclear. Ask specifically: "Is prior authorization required for metformin prescribed for [your diagnosis]?"

5. If PA is required, ask your prescriber's office to initiate it and provide your lab results. Most PA decisions for metformin are resolved within three to five business days.

Cash Price as a Backup

If you are in a deductible phase or if your PA is delayed, generic metformin is one of the cheapest drugs available at retail. At major pharmacy chains and discount programs, a 90-day supply of generic metformin 500 mg twice daily typically costs between $4 and $20 without insurance, often less with a GoodRx or similar discount card. This means you do not have to delay starting treatment while a PA is processed.

What Quartz Coverage Looks Like for Metformin ER vs. Immediate-Release

Not all metformin formulations are treated equally on formularies. This distinction matters practically for women who have GI side effects on immediate-release.

| Formulation | Typical Quartz Tier | Estimated Copay (30-day) | PA Likely? | |---|---|---|---| | Metformin IR 500 mg, 850 mg, 1000 mg (generic) | Tier 1 | $0 to $10 | Only for off-label use | | Metformin ER 500 mg, 750 mg, 1000 mg (generic) | Tier 1 to Tier 2 | $0 to $20 | Only for off-label use | | Glumetza (brand ER) | Tier 3 or non-formulary | $50 or more | Yes | | Fortamet (brand ER) | Non-formulary | Full cost | Yes |

If your clinician prescribes "metformin ER" and allows generic substitution, you will almost always get the lower-cost generic version dispensed by the pharmacy, which is clinically equivalent to the branded versions for most women.

The brand-name formulations Glumetza and Fortamet are rarely covered at preferred tiers on regional commercial plans like Quartz, and paying out of pocket for them rarely makes clinical sense when the generic ER achieves the same GI tolerability benefit.

Common Questions Women Ask About Metformin and Insurance

Women calling their insurance or pharmacy often ask versions of the same questions. Here are the answers your clinician or member services representative should be giving you.

"My prescriber wrote metformin for PCOS. Will Quartz cover it?"

Possibly. The formulary tier is the same regardless of indication, the question is whether your plan requires PA for off-label use. Ask your prescriber's office to submit the PA with your PCOS diagnosis code and relevant metabolic labs. Approval rates for metformin PA in PCOS are generally high when documentation is complete because the clinical evidence base is well-established.

"I'm on a high-deductible Quartz plan. How much will I pay?"

Until your deductible is met, you will pay the negotiated rate for the drug, not the full retail price and not $0. For generic metformin, the negotiated rate on most plans is between $8 and $30 for a 30-day supply, which is still affordable for most women. After your deductible is met, you drop to the Tier 1 copay.

"Can I use GoodRx with my Quartz insurance?"

You cannot combine GoodRx with insurance at the same transaction. You pick one or the other at the register. For generic metformin, the GoodRx price is often lower than what you would pay under insurance during a deductible phase, so it is worth comparing before you hand over your insurance card.